As breakthroughs in cancer treatments are occurring at an ever increasing rate, The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances.
Through its significant investment in cancer research – more than $1.2 billion since its founding nearly 70 years ago – LLS is committed to funding and recognizing female scientists, physicians, social workers and nurses, and encouraging young women to participate in STEM (science, technology, engineering and math) education and pursue careers in the sciences.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128552-lls-women-in-science/
For over 10 years we at Middle Passage Consulting have given small business owners options that allow them to increase their return on their investments and increase their revenue. We offer much more than bridge loans and merchant cash advances. Here we assist with term loans, venture capital, health financing, equipment loans, asset based funding, purchase order funding, commercial real estate funding. If it's business funding we can help!
https://www.youtube.com/watch?v=p27dqEAOoew
Positive strides have been made since 1995 to advance science literacy in the United States, but teachers and parents agree that more hands-on, experiential learning must be adopted in order to improve science education for future generations, according to the results of the 2015 Bayer Facts of Science Education Survey released today.
For 20 years, Bayer has issued the survey, which assesses science education in the United States and evaluates its development. Although positive strides have been made, survey results emphasize the critical need to improve science education and literacy for future generations. Teachers, for example, universally agree (99 percent) that more hands-on experiential learning in general would benefit student learning.
In response, Bayer is announcing a five-year commitment to provide 1 million hands-on science learning experiences for children by 2020, timed to the 20th anniversary of the Making Science Make Sense® program, Bayer’s company-wide initiative that advances science literacy across the United States.
To view the multimedia release go to:
http://www.multivu.com/players/English/7452954-bayer-children-science-education/
The Smithsonian's National Museum of American History will open a new exhibition on American business July 1 in the Mars Hall of American Business. The exhibition, “American Enterprise” will have a strong focus on the nation's agriculture history which is one of four economic sectors in the exhibition. It will explore precision farming, environmental concerns and hybrid seeds.
“American agriculture has gone through a tremendous transformation in the past seven decades, becoming a high-tech industry, deeply affecting not just farmers themselves but every American and the American experience in general,” said Peter Liebhold, museum curator and chair of the Division of Work and Industry.
The companion book American Enterprise: A History of Business in America, will highlight significant artifacts from agriculture's humble beginnings to the technological advances that make it a leading industry in the United States.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7433931-national-museum-of-american-history/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Leading frozen bread manufacturer and the original inventor of frozen garlic bread, Cole’s Quality Foods, Inc., innovates the frozen food category yet again with the introduction of Middles™, a stuffed bread that combines delicious, decadent, savory, salty and sweet flavors into one revolutionary snack concept.
Middles become available later this month in the freezer section at grocery, club, supermarket and convenience stores nationwide for a suggested retail price of $3.99 per 10.8-ounce box. Each box contains eight tasty bread bites.
Inspired by the much-celebrated combination of bread and cheese, Middles advances the concept by featuring the soft “middle” section of popular bakery staples, including bagel, Italian and pretzel breads. They are then stuffed with savory and sweet centers, including cheddar cheese, cream cheese, and beer cheese varieties. The result is an outrageously delicious heat-and-serve stuffed bread snack that can be made in either microwave or conventional ovens in just seven to nine minutes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8139251-coles-frozen-bread-middles/
Nearly five dozen 2019 models meet stricter criteria to qualify for a 2019 TOP SAFETY PICK+ or TOP SAFETY PICK award from the Insurance Institute for Highway Safety. The 30 first-tier “plus” award winners earn the highest rating for passenger-side protection in a small overlap front crash and have good-rated available headlights, while the 27 winners of the second-tier award qualify with an acceptable or higher rating in the newest IIHS crash test and the nighttime headlight evaluation.
All 57 vehicles in this elite group earn good ratings in the Institute’s five other crashworthiness evaluations and have an available automatic emergency braking system that rates advanced or superior for front crash prevention.
IIHS now requires a good rating in the passenger-side small overlap front test to earn a 2019 TOP SAFETY PICK+ versus an acceptable or good rating for the 2018 award. An acceptable or good rating in the passenger-side test is a new criterion to earn a 2019 TOP SAFETY PICK.
This marks the sixth time that IIHS has raised the bar to earn the TOP SAFETY PICK+ award since introducing it in the 2013 model year to recognize vehicles that offer a superior level of safety. The TOP SAFETY PICK accolade launched in the 2006 model year to help consumers identify vehicles with the highest ratings. Over the years, IIHS has added to and strengthened criteria for both awards to encourage manufacturers to speed up safety advances.
